SCHEMBL9825071

SCHEMBL9825071

C=CCc1cc[nH]c1C(=O)O

nearest known ligand 0.39

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
PTGDR Q13258 1/20 0.36
PTGDR2 Q9Y5Y4 1/20 0.36
GABRA1 P14867 2/20 0.35
GABRB2 P47870 2/20 0.35
POLB P06746 1/20 0.34
ALDH1A1 P00352 5/20 0.33
KDM4E B2RXH2 4/20 0.33
HPGD P15428 2/20 0.33
ENPP2 Q13822 1/20 0.33
HSD17B10 Q99714 1/20 0.33
L3MBTL1 Q9Y468 1/20 0.33
HTT P42858 2/20 0.33
MAPT P10636 1/20 0.32
LMNA P02545 1/20 0.31
ELANE P08246 1/20 0.31
SRD5A1 P18405 1/20 0.30
CYP2C19 P33261 1/20 0.30
TSHR P16473 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3268284 0.80 CNR2 (0.38) PTGDRPTGDR2POLBALDH1A1KDM4E
SCHEMBL27463814 0.78 MAPT (0.31) ALDH1A1KDM4EHSD17B10MAPTCYP2C19
SCHEMBL8741425 0.77 MAPK1 (0.44) POLBALDH1A1KDM4EHPGDHSD17B10
SCHEMBL519233 0.76 ALDH1A1 (0.39) GABRA1GABRB2ALDH1A1KDM4EHPGD
SCHEMBL1491958 0.76 PARP1 (0.34) ALDH1A1KDM4EHPGDENPP2HSD17B10
SCHEMBL8056032 0.75 PTGDR (0.37) PTGDRPTGDR2GABRA1GABRB2POLB
SCHEMBL16236670 0.75 KDM4E (0.32) ALDH1A1KDM4EHPGDENPP2HSD17B10
SCHEMBL384597 0.75 HTR7 (0.33) ALDH1A1KDM4EHPGDENPP2HSD17B10
SCHEMBL11865883 0.75 AKR1B1 (0.42) POLBALDH1A1KDM4EHPGDHSD17B10
SCHEMBL8718496 0.72 GABRA1 (0.48) GABRA1GABRB2POLBALDH1A1KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-105800578-B Air bubble liquid-membrane method production ultra micro, the method for nano ferric phosphate 杨第伦 2018-04-24 CN disclosed
EP-0381141-A3 NOVEL ARYL- OR HETEROARYL-1-ALKYL-PYRROLE-2-CARBOXYLIC ACID COMPOUNDS USEFUL IN TREATING INTERLEUKIN-1 MEDIATED CONDITIONS MERRELL PHARMACEUTICALS INC. (US) 1991-11-21 EP disclosed
EP-0381141-A2 Novel aryl- or heteroaryl-1-alkyl-pyrrole-2-carboxylic acid compounds useful in treating interleukin-1 mediated conditions MERRELL PHARMACEUTICALS INC. (US) 1990-08-08 EP disclosed
EP-0381142-A2 Method of using aryl-or heteroaryl-1-alkyl-pyrrole-2-carboxylic acid compounds in the treatment of interleukin-1 mediated conditions MERRELL DOW PHARMACEUTICALS INC. (US) 1990-08-08 EP disclosed